Skip to content
  • Brazil
  • Canada
  • Europe
  • India
  • Italy
  • Japan
  • Korea
  • Latam
  • Spain
  • Taiwan
  • The Middle East
  • Turkey
  • United Kingdom
  • United States
  • Country/Region
  • No block ID is set

  • Clinic Portal
    • +0034963905310
  • Request Information
  • +34 96 390 53 10
  • Part of brands: |
InternationalInternational
  • Country/Region
  • Part of brands: |
  • Patient Journey
    • Before Pregnancy
    • IVF Process
    • Healthy pregnancy
    • After birth
  • Reproductive Health
    • Specialists
      • ERA
      • ERA insight Hub
      • ALICE
      • EMMA
      • EndomeTRIO
      • Infertility Panels
      • EMBRACE
      • PGT-A
      • PGT-A Plus
      • PGT-M
      • PGT-SR
      • CGT
      • NACE
      • Zenit
      • POC Portfolio
      • SAT
      • Newborn Screening
  • Diagnostics
  • About us
    • Igenomix Research
    • About Igenomix
    • Igenomix Worldwide
  • Academy
  • Blog
Genomics Precision Diagnostic > Neurology Precision Panel > Dystonia Precision Panel

Dystonia Precision Panel

Dystonia is a heterogeneous movement disorder featuring sustained or intermittent muscle contractions causing abnormal, often repetitive movements, postures or both. Dystonic movements are typically patterned and twisting, even tremulous. 
Overview
Indication
Clinical Utility
Genes & Diseases
Methodology
References

Overview

  • Dystonia is a heterogeneous movement disorder featuring sustained or intermittent muscle contractions causing abnormal, often repetitive movements, postures or both. Dystonic movements are typically patterned and twisting, even tremulous. It is generally initiated or worsened by voluntary action and associated with overflow muscle activation. Out of the different types of dystonia, focal dystonia, more specifically cervical dystonia is the most common and is approximately 10 times more frequent than generalized dystonia. Their clinical heterogeneity accounts for a profound effect on the personal, vocational, and emotional life of a patient and can impact greatly his/her ability to live independently. Dystonia may be inherited, acquired, or idiopathic. A strong genetic component has been identified in familial dystonia syndromes.  

  • The Igenomix Dystonia Precision Panel  can serve as an accurate and directed diagnostic tool ultimately as well as a differential diagnosis of muscle cramps leading to a better management and prognosis of the disease. It provides a comprehensive analysis of the genes involved in this disease using next-generation sequencing (NGS) to fully understand the spectrum of relevant genes involved. 

Indication

  • The Igenomix Dystonia Precision Panel is indicated in patients with a clinical suspicion or diagnosis presenting with or without the following manifestations: 
    • Uncontrolled muscle cramps and spasms 
    • Body twisting and unusual positions 
    • Shanking (tremors) 
    • Uncontrolled blinking 

Clinical Utility

The clinical utility of this panel is: 

  • The genetic and molecular diagnosis for an accurate clinical diagnosis of a symptomatic patient.  
  • Early initiation of treatment with a multidisciplinary team in the form of pharmacologic therapy with anticholinergics, intramuscular botulinum toxin injection and/or deep brain stimulation. 
  • Risk assessment and genetic counselling of asymptomatic family members according to the mode of inheritance. 
  • Improvement of delineation of genotype-phenotype correlation.

Genes & Diseases

Methodology

References

See scientific referrals

Skogseid I. M. (2014). Dystonia–new advances in classification, genetics, pathophysiology and treatment. Acta neurologica Scandinavica. Supplementum, (198), 13–19. https://doi.org/10.1111/ane.12231 

Lohmann, K., & Klein, C. (2017). Update on the Genetics of Dystonia. Current neurology and neuroscience reports, 17(3), 26. https://doi.org/10.1007/s11910-017-0735-0 

Steeves, T., Day, L., Dykeman, J., Jette, N., & Pringsheim, T. (2021). The prevalence of primary dystonia: A systematic review and meta-analysis. Retrieved 31 March 2021 

Vidailhet, M., Méneret, A., & Roze, E. (2020). Dystonia: genetics, phenomenology, and pathophysiology. The Lancet. Neurology, 19(11), 881–882. https://doi.org/10.1016/S1474-4422(20)30366-5 

Balint, B., Mencacci, N. E., Valente, E. M., Pisani, A., Rothwell, J., Jankovic, J., Vidailhet, M., & Bhatia, K. P. (2018). Dystonia. Nature reviews. Disease primers, 4(1), 25. https://doi.org/10.1038/s41572-018-0023-6 

Albanese, A., Barnes, M., Bhatia, K., Fernandez-Alvarez, E., Filippini, G., & Gasser, T. et al. (2006). A systematic review on the diagnosis and treatment of primary (idiopathic) dystonia and dystonia plus syndromes: report of an EFNS/MDS-ES Task Force. European Journal Of Neurology, 13(5), 433-444. doi: 10.1111/j.1468-1331.2006.01537.x 

Schwarz, C. S., & Bressman, S. B. (2009). Genetics and treatment of dystonia. Neurologic clinics, 27(3), 697–vi. https://doi.org/10.1016/j.ncl.2009.04.010 

descargar

Detail description

Download

Request Information

WE GUIDE YOU

Fertility
Inherited diseases prevention
Healthy pregnancy

To see the accreditation certificate, associated technical annex and list of accredited tests, click on this link.

OUR SERVICES

Genetic testing solutions
For patients
How to send a sample?
User manual

ABOUT US

About Igenomix
Contact
Quality
Complaints
Work with us
Terms and conditions

FOLLOW IGENOMIX

  + 96 390 53 10
  Write us
  • Brazil
  • Canada
  • Europe
  • India
  • Italy
  • Japan
  • Korea
  • Latam
  • Spain
  • Taiwan
  • The Middle East
  • Turkey
  • United Kingdom
  • United States
Country/Region

[2024] © Igenomix Privacy Page Quality policy Legal note Cookies policy

Request Information


  • Patient Journey
    • Before Pregnancy
    • IVF Process
    • Healthy pregnancy
    • After birth
  • Reproductive Health
    • Specialists
      • ERA
      • ERA insight Hub
      • ALICE
      • EMMA
      • EndomeTRIO
      • Infertility Panels
      • EMBRACE
      • PGT-A
      • PGT-A Plus
      • PGT-M
      • PGT-SR
      • CGT
      • NACE
      • Zenit
      • POC Portfolio
      • SAT
      • Newborn Screening
  • Diagnostics
  • About us
    • Igenomix Research
    • About Igenomix
    • Igenomix Worldwide
  • Academy
  • Blog
  • Country/Region
  • +34 96 390 53 10
  • Clinic Portal
  • Request Information